INS and dementia: A network meta-analysis by Zhou et al. [19] found that patients with diabetes who were treated with DPP-4 inhibitors were associated with a lower dementia risk than those treated with metformin and thiazolidinedione, whereas treatment with insulin was associated with a higher risk.